AstraZeneca (AZN) Pharma and Biotech Sector

  • Latest quote

    6,130.00p (mid)

  • Current Change (%)

    0.02%

  • Price

    Bid: 6,102.00p

    Offer: 6,104.00p

  • Today

    High: 6,158.00p

    Low: 6,069.00p

  • This year

    High: 6,317.00p

    Low: 4,712.50p

  • Information

    Volume: 758,988

    Market Cap: £77605.8M



AstraZeneca Overview

A world-leading pharmaceutical group, AstraZeneca was created in 1999 via the merger of Sweden's Astra and the UK's Zeneca, which had been demerged from chemicals group ICI in 1993. About half of its total sales are generated from the US, with over a third of revenues coming from its gastrointestinal treatments such as Prilosec (Losec) and Nexium.

AstraZeneca RNS Feed

Title Release date
Update on the Phase III EAGLE trial of Imfinzi 07:00 - December 7, 2018
Divestment of rights to Covis completed 07:00 - December 6, 2018
Director/PDMR Shareholding 15:00 - December 4, 2018
Total Voting Rights 16:00 - December 3, 2018
Block listing Interim Review 16:00 - December 3, 2018
Grünenthal Agreement for Nexium, Vimovo Completed 07:00 - December 3, 2018
US FDA grants Fasenra ODD for EGPA 07:00 - November 26, 2018
AstraZeneca provides update on Phase III MYSTIC 07:00 - November 16, 2018
AstraZeneca to divest US Synagis rights to Sobi 07:00 - November 13, 2018
US FDA accepts regulatory submission for Lynparza 07:05 - November 12, 2018
Farxiga significantly reduced hospitalisation for 07:00 - November 12, 2018
AZN: Year-to-Date and Q3 2018 Results 07:00 - November 8, 2018
Divestment of rights to Covis Pharma 07:00 - November 6, 2018
Total Voting Rights 15:00 - November 1, 2018
Additional financial information-Grünenthal deal 09:45 - October 31, 2018

NOTE: This is based on 192 open tips for this company


Total Number of Share tips :

397

View all AstraZeneca Tips



Daily share tips delivered straight to your pc, tablet & mobile

Join Free Today